Tech Company Financing Transactions

Verve Therapeutics Funding Round

GV, Arch Venture Partners and Biomatics Capital Partners joined a $58.5 million Series A funding round for Verve Therapeutics. The financing round was announced on 5/8/2019.

Transaction Overview

Company Name
Verve Therapeutics
Announced On
5/8/2019
Transaction Type
Venture Equity
Amount
$58,500,000
Round
Series A
Investors

GV (Lead Investor) (Krishna Yeshwant)

Arch Venture Partners (John Evans)

Biomatics Capital Partners

F-Prime Capital

Proceeds Purpose
The funds raised will be used to advance the pre-clinical programs through proof-of-concept studies.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
500 Technology Sq. 901
Cambridge, MA 02139
USA
Phone
(617) 603-0070
Website
www.vervetx.com
Email Address
Not Recorded
Overview
Verve is focused on discovering and developing therapies that safely edit the genomes of adults to confer protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.
Profile
Verve Therapeutics LinkedIn Company Profile
Social Media
Verve Therapeutics Company Twitter Account
Company News
Verve Therapeutics News
Facebook
Verve Therapeutics on Facebook
YouTube
Verve Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chairman
Burt Adelman
  Burt Adelman LinkedIn Profile  Burt Adelman Twitter Account  Burt Adelman News  Burt Adelman on Facebook
Chief Executive Officer
Sekar Kathiresan
  Sekar Kathiresan LinkedIn Profile  Sekar Kathiresan Twitter Account  Sekar Kathiresan News  Sekar Kathiresan on Facebook
Chief Scientific Officer
Andrew Bellinger
  Andrew Bellinger LinkedIn Profile  Andrew Bellinger Twitter Account  Andrew Bellinger News  Andrew Bellinger on Facebook
Co-Founder
Keith Joung
  Keith Joung LinkedIn Profile  Keith Joung Twitter Account  Keith Joung News  Keith Joung on Facebook
Co-Founder
Kiran Musunuru
  Kiran Musunuru LinkedIn Profile  Kiran Musunuru Twitter Account  Kiran Musunuru News  Kiran Musunuru on Facebook
Co-Founder
Anthony Philippakis
  Anthony Philippakis LinkedIn Profile  Anthony Philippakis Twitter Account  Anthony Philippakis News  Anthony Philippakis on Facebook
Co-Founder
Issi Rozen
  Issi Rozen LinkedIn Profile  Issi Rozen Twitter Account  Issi Rozen News  Issi Rozen on Facebook
Co-Founder
Barry Ticho
  Barry Ticho LinkedIn Profile  Barry Ticho Twitter Account  Barry Ticho News  Barry Ticho on Facebook
President
Andrew Ashe
  Andrew Ashe LinkedIn Profile  Andrew Ashe Twitter Account  Andrew Ashe News  Andrew Ashe on Facebook
Vice President
Kallanthottathil Rajeev
  Kallanthottathil Rajeev LinkedIn Profile  Kallanthottathil Rajeev Twitter Account  Kallanthottathil Rajeev News  Kallanthottathil Rajeev on Facebook
Vice President
Ellen Rohde
  Ellen Rohde LinkedIn Profile  Ellen Rohde Twitter Account  Ellen Rohde News  Ellen Rohde on Facebook
VP - Manufacturing
Christopher Cheng
  Christopher Cheng LinkedIn Profile  Christopher Cheng Twitter Account  Christopher Cheng News  Christopher Cheng on Facebook
VP - Marketing
Michele Rozen
  Michele Rozen LinkedIn Profile  Michele Rozen Twitter Account  Michele Rozen News  Michele Rozen on Facebook
VP - R & D
Alexandra Chadwick
  Alexandra Chadwick LinkedIn Profile  Alexandra Chadwick Twitter Account  Alexandra Chadwick News  Alexandra Chadwick on Facebook
VP - Regulatory Affairs
Leslie Stolz
  Leslie Stolz LinkedIn Profile  Leslie Stolz Twitter Account  Leslie Stolz News  Leslie Stolz on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/8/2019: OSF Digital venture capital transaction
Next: 5/8/2019: Data Gumbo venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.